THE INCIDENCE OF ED AFTER TURP AND TVP ON BPH PATIENTS

##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

PDF
Published 2012-01-01
Aries Alpendri Tjahyo Kelono Utomo Trisula Utomo Prawito Singodimedjo

Abstract

Objective: The aim of this study was to know the incidence of erectile dysfunction (ED) after transurethral resections of the prostate (TURP) and transvesical prostatectomy (TVP). Material & method: Data were collected in 1 year period from January until December 2005 with cross sectional study design. There were 60 patients who met the inclusion and exclusion criteria and patient who participated in this study underwent TURP and TVP and divided in TURP group and TVP group. Erectile Dysfunction measured by International Index of Erectile Function-5 (IIEF-5) data was analyzed by statistic chi-square and independent t-test. Results: Sixty patients include this study with 30 patients in each group. The mean age of TURP was 64 ± 5,68 and TVP was 63,23 ± 4,83 with age ranging from 50 – 70 years. The incidence of ED after TURP and TVP was 36,67% and 16,70% respectively with p = 0,08. The IIEF-5 scores for TURP and TVP was 19,40 ± 3,95 and 21,03 ± 2,57 respectively and by statistical analysis the differences was not significant. Conclusion: The incidence of ED after TURP showed higher than TVP and by statistical analysis the differences was not significant. Keywords: Benign prostatic hyperplasia, erectile dysfunction, transurethral resection of the prostate, transvesical prostatectomy.


##plugins.themes.bootstrap3.article.details##

References

Ekman P. BPH epidemiology and risk factors. Prostate Suppl. 1989; 2: 23-31.

Morrison AS. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol. 1992; 135: 974-80.

Altwein JE, Keuler FU. Benign prostatic hyperplasia and erectile dysfunction: A review. Urol Int. 1992; 48: 53-7.

Sweeney M, Roehrborn C, Boyle P. Sexual dysfunction in European patients with benign prostatic hyperplasia (BPH). J Urol. 1997; 157: 330a.

McConnell JD, Barry MJ, Bruskewitz RC. Benign prostatic hyperplasia: Diagnosis and treatment. Clinical Practice Guideline, No. 8. AHCPR publication No. 94-0582, Rockville, Md. Agency for Health Care Policy and Research, Public Health Service: US Department of Health and Human Services; 1994.

Denis L, Griffiths K, Khoury S. Proceedings of the 4th international consultation on BPH. Plymouth, United Kingdom: Health Publication; 1998.

Presti JC. Neoplasms of the prostate gland. In: Smith’s General Urology. 17th ed. Tanagho EA, Mc Annich JW (ed). USA: A Lange Medical Book; 2003. p. 399-417.

Han M, Alfert HJ, Partin AW. Retropubic and suprapubic open prostatectomy. In: Campbell’s Urology. 8th Ed. St. Louis: Elsevier Science; 2002: 2.

Leslie SW. Resection of the prostate. Available at www.e-medicine.com

Thierny LM, Mc Phee SJ, Papadakis MA. Benign prostate hyperplasia in current medical diagnosis and treatment. 43rd ed. A Lange Medical Book/Mc Graw-Hill; 2004. p. 922-8.

Poulakis V, Ferakis N, Witzsch U. Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: Result from center with over 500 patients. Asian J of And. 2006; 8(1): 69.

Ozkara H, Alici B, Akkus E. Effect of TUR-P and transvesical prostatectomy on sexual functions. Cerrahpasa J Med. 1998; 29: 132-6.

Pawlicki B, Galka M, Mrozicki S. Erectile dysfunction following transurethral resection of the prostate following bladder outlet obstruction. Seksuologia Polska. 2003; 1(2): 47-50.

Taher A. Erectile dysfunction after transurethral resection of the prostate: Incidence and risk factors. World J Urol. 2004; 23(6).

Oh SK, Lee KS, Choi HY. Clinical result comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostate hyperplasia. Korean J Urol. 1998; 39(8): 777-82.

Section
January 2012 Vol. 19 No. 1
Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University